SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

242.5445604

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

35.89

13002.56

EPS(TTM)

Face Value()

Div & Yield %

47.66

0.35

Back

MRF consolidated net profit rises 119.32% in the December 2025 quarter

Feb 06,2026

Net profit of MRF rose 119.32% to Rs 691.83 crore in the quarter ended December 2025 as against Rs 315.45 crore during the previous quarter ended December 2024. Sales rose 14.99% to Rs 8050.43 crore in the quarter ended December 2025 as against Rs 7000.82 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8050.43	7000.82	15
OPM %	17.38	11.92	-
PBDT	1432.59	839.17	71
PBT	994.56	424.18	134
NP	691.83	315.45	119

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)